142 related articles for article (PubMed ID: 28589706)
41. Suppression of inflammation during cell-free concentrated ascites reinfusion therapy using a blood purification device.
Ohashi A; Nakai S; Hori H; Yamada S; Kato M; Koide S; Hayashi H; Tsuboi N; Inaguma D; Hasegawa M; Yuzawa Y
Ther Apher Dial; 2020 Oct; 24(5):511-515. PubMed ID: 32526100
[TBL] [Abstract][Full Text] [Related]
42. Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study.
Ishitani K; Isoai A; Ito T; Sugiyama H; Arakawa A; Yamada Y; Onodera H; Kobayashi R; Torii N; Soneda N; Matsuno Y; Utsugisawa T; Kato M; Hanafusa N
Int J Clin Oncol; 2021 Jun; 26(6):1130-1138. PubMed ID: 33761026
[TBL] [Abstract][Full Text] [Related]
43. Feasibility, efficacy, and safety of cell-free and concentrated ascites reinfusion therapy (KM-CART) for malignant ascites.
Matsusaki K; Orihashi K
Artif Organs; 2020 Oct; 44(10):1090-1097. PubMed ID: 32242939
[TBL] [Abstract][Full Text] [Related]
44. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.
Nagata Y; Kato K; Miyamoto T; Hirano H; Shoji H; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Matsushita H; Nagashima K; Saruta M; Boku N
Support Care Cancer; 2020 Dec; 28(12):5861-5869. PubMed ID: 32253601
[TBL] [Abstract][Full Text] [Related]
45. A Method for Stabilizing the Proportion of the Reduced Form of Albumin During Cell-Free and Concentrated Ascites Reinfusion Therapy in Patients with Malignant Ascites.
Ohashi A; Nakai S; Yamada S; Kato M; Hasegawa M
Ther Apher Dial; 2019 Jun; 23(3):242-247. PubMed ID: 31033167
[TBL] [Abstract][Full Text] [Related]
46. Concentrated ascitic fluid reinfusion after cascade filtration in tense ascites.
Rossaro L; Graziotto A; Bonato S; Plebani M; van Thiel DH; Burlina A; Naccarato R; Salvagnini M
Dig Dis Sci; 1993 May; 38(5):903-8. PubMed ID: 8482189
[TBL] [Abstract][Full Text] [Related]
47. Ascites reinfusion dialysis (ARD) for renal failure with refractory ascites.
McGill RL; Bakos JR; Marcus RJ
Clin Nephrol; 2004 Nov; 62(5):374-9. PubMed ID: 15571183
[TBL] [Abstract][Full Text] [Related]
48. Quality of life assessment of cell-free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study.
Yamamoto K; Nagao S; Tsu T; Matsushima T; Ishido Y; Narita M; Suzuki K; Nakazawa H; Shibutani T; Jimi T; Yano H; Kitai M; Shiozaki T; Matsuoka K; Yamaguchi S
J Obstet Gynaecol Res; 2021 Apr; 47(4):1536-1543. PubMed ID: 33469981
[TBL] [Abstract][Full Text] [Related]
49. Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report.
Yasuda K; Asou M; Asakawa T; Araki M
J Med Case Rep; 2020 Oct; 14(1):192. PubMed ID: 33050943
[TBL] [Abstract][Full Text] [Related]
50. Investigation of Endotoxin Positivity in Ascites at the Time of Cell-free and Concentrated Ascites Re-infusion Therapy.
Ohara T; Setsuhara C; Nakao S; Noguchi Y; Shimazu K; Komura K; Tanaka A
Intern Med; 2023 Nov; 62(21):3119-3123. PubMed ID: 36858521
[TBL] [Abstract][Full Text] [Related]
51. Prevention of the febrile reaction occurring on reinfusion of cell-free and concentrated autogenous ascites.
Katoh S; Tatsukawa H; Kondoh M; Inoue M; Ida K; Miyagawa F
Jpn J Med; 1991; 30(4):311-7. PubMed ID: 1942641
[TBL] [Abstract][Full Text] [Related]
52. Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy.
Namisaki T; Tsuji Y; Kitade M; Yorioka N; Fujinaga Y; Sawada Y; Nishimura N; Kitagawa K; Inoue T; Takaya H; Kaji K; Kawaratani H; Moriya K; Akahane T; Mitoro A; Yoshiji H
In Vivo; 2022; 36(3):1477-1484. PubMed ID: 35478114
[TBL] [Abstract][Full Text] [Related]
53. A case of cell-free and concentrated ascites reinfusion therapy effective for refractory ascites in spontaneous bacterial peritonitis in a renal transplant patient.
Maeda A; Takeda K; Tsuruya K; Miura S; Toyonaga J; Nakashita S; Furushou M; Mukai H; Mutou Y; Komaki T; Takae K; Yasunaga C
Case Rep Nephrol Urol; 2012 Jul; 2(2):138-44. PubMed ID: 23289021
[TBL] [Abstract][Full Text] [Related]
54. Effective recovery of highly purified CD326(+) tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART).
Kimura Y; Harada Y; Yasuda N; Ishidao T; Yusa S; Matsusaki K; Yonemitsu Y
Springerplus; 2015; 4():780. PubMed ID: 26702369
[TBL] [Abstract][Full Text] [Related]
55. [Refractory ascites developing in late-phase of cord blood transplantation improving with CART].
Hiroi T; Mushino T; Tanaka K; Yamashita Y; Kuriyama K; Murata S; Furuya Y; Hori Y; Oiwa T; Kobata H; Hosoi H; Nishikawa A; Tamura S; Sonoki T
Rinsho Ketsueki; 2019; 60(2):130-133. PubMed ID: 30842380
[TBL] [Abstract][Full Text] [Related]
56. Biochemical evaluation of processed ascites in patients undergoing cell-free and concentrated ascites reinfusion therapy.
Nakamura H; Hanafusa N; Kitamura K; Nakamura H; Sekihara H; Shimizu K; Anayama M; Makino Y; Tamura K; Nagasawa M
Ther Apher Dial; 2020 Oct; 24(5):516-523. PubMed ID: 32524759
[TBL] [Abstract][Full Text] [Related]
57. [Breast Cancer with Cancerous Ascites with Good QOL by KM-CART-A Case Report].
Iimori N; Nishimura S; Kushitani Y; Tokumoto M; Taenaka N; Terashima K
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1983-1985. PubMed ID: 33468774
[TBL] [Abstract][Full Text] [Related]
58. Protein Concentration of Refractory Ascites in Cancer Patients is Reflected by the Presence and Severity of Peritoneal and Liver Metastasis.
Yamada Y; Yamaguchi A; Harada M; Kurasawa Y; Hara Y; Yamazaki D; Fujita S; Sonoda K; Masuda T; Yamada A; Ogawa Y; Hashimoto K; Kamijo Y
Ther Apher Dial; 2017 Jun; 21(3):263-269. PubMed ID: 28661095
[TBL] [Abstract][Full Text] [Related]
59. Cell-free and concentrated ascites reinfusion therapy for refractory massive cardiac ascites in an adult with single ventricle haemodynamics: a case report.
Tsukishiro Y; Yamamoto H; Masumoto A; Takaya T
Eur Heart J Case Rep; 2023 Mar; 7(3):ytad081. PubMed ID: 36895305
[TBL] [Abstract][Full Text] [Related]
60. Reinfusion of autogenous ascitic fluid concentrated by freezing in patients with intractable ascites.
Chiyoda S; Morikawa T; Matsuo K; Masuya S
Intern Med; 1992 Mar; 31(3):325-32. PubMed ID: 1611182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
